Chaim Lebovits - 21 May 2024 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & CEO
Signature
/s/ Chaim Lebovits
Issuer symbol
BCLI
Transactions as of
21 May 2024
Net transactions value
+$30,475
Form type
4
Filing time
23 May 2024, 06:00:11 UTC
Previous filing
31 Jul 2024
Next filing
31 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $14,475 +25,000 +2.3% $0.5790 1,124,865 21 May 2024 Direct
transaction BCLI Common Stock Award $16,000 +25,000 +2.2% $0.6400 1,149,865 22 May 2024 Direct
holding BCLI Common Stock 2,000,847 21 May 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.